美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPDR S&P Biotech ETF

154.03

-3.5700-2.27%

盤後：154.100.0700+0.05%19:59 EDT

成交量：1,130.06萬

成交額：17.39億

市值：102.28億

市盈率：8.45

高：157.53

開：157.08

低：152.63

收：157.60

52周最高：169.89

52周最低：93.26

股本：6,640.00萬

流通股本：6,640.00萬

量比：1.47

換手率：17.02%

股息：0.57

股息率：0.37%

每股收益(TTM):18.23

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

從護膚到大健康，植物醫生想成為一家生物科技公司

生物醫藥公司扎堆「趕考」港交所，「A+H」上市模式受青睞

醫療保健板塊市場快訊：比特幣漲勢帶動加密市場樂觀情緒，阿斯利康新藥潛力引關注

醫療健康板塊市場綜述：行業動態與個股追蹤

美國衞生與公眾服務部醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.2億美元，用於擴大印第安納州母嬰健康服務，提高初級

American Healthcare REIT（AHR）宣佈完成收購八個高端養老社區涉資近7億美元

鄉村振興 | 一粒「蛋白」的農田奇遇：看盤山如何用生物科技解鎖豐收密碼

醫療保健板塊綜述：市場快訊

跨國巨頭，入局鄭州航空港區中原醫學科學城

河南日报客户端

這些女性在休產假期間被解僱。是的，這合法，而且可能比你想象的更常見

环球市场播报

醫療保健板塊市場快訊匯總

北京：聚焦集成電路、生物醫藥、航空航天、高端裝備等優勢產業，鞏固對外貿易傳統市場

派格生物醫藥-B(02565.HK)與SN BioScience訂立材料轉移協議推進包括APGP6在內的三款下一代代謝疾病創新多肽候選藥物長效化開發

醫療保健板塊動態：市場快訊匯總

貫徹實施民營經濟促進法典型案例（第二批）

【「十五五」開局看趙縣——生物醫藥篇】創新驅動增動能科技賦能產業升級

北京成立生物醫藥等三個共保體支持科技創新

百濟神州：PD-1抗癌藥降價加入美國公共醫療保險計劃今後上市創新藥均將執行最惠國定價

每日经济新闻

生物醫藥邁向「源頭創新」

北京：聚焦集成電路、生物醫藥、航空航天、高端裝備等優勢產業，鞏固對外貿易傳統市場

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/XBI/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":154.03,"timestamp":1789502400000,"preClose":157.6,"halted":0,"volume":11300561,"hourTrading":{"tag":"盘后","latestPrice":154.1,"preClose":154.03,"latestTime":"19:59 EDT","volume":217310,"amount":33483251.403,"timestamp":1789516796776,"change":0.07,"changeRate":0.000454,"amplitude":0.001883},"delay":0,"changeRate":-0.02265228426395935,"floatShares":66400000,"shares":66400000,"eps":18.23,"marketStatus":"已收盤","change":-3.57,"latestTime":"09-15 16:00:00 EDT","open":157.08,"high":157.53,"low":152.63,"amount":1738536841.14598,"amplitude":0.031091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":157.6,"sharesOutstanding":63325000,"nav":157.586874,"aum":10743485169.21,"dividendRate":0.003684,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":157.17,"preClose":157.6,"latestTime":"09:29 EDT","volume":2906,"amount":456673.94784,"timestamp":1789478999999,"change":-0.43,"changeRate":-0.002728,"amplitude":0.005162},"postHourTrading":{"tag":"盘后","latestPrice":154.1,"preClose":154.03,"latestTime":"19:59 EDT","volume":217310,"amount":33483251.403,"timestamp":1789516796776,"change":0.07,"changeRate":0.000454,"amplitude":0.001883},"volumeRatio":1.474873,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1792123200000,"strike":"150.0","timestamp":1789502340274,"price":3.85,"volume":15000,"amount":5775000,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"158.0","timestamp":1789502340274,"price":4.52,"volume":15000,"amount":6780000,"type":"-"}]},"impliedVol":0.319,"impliedVolPercentile":0.6175},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":66400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.474873,"shares":66400000,"dividePrice":0.5674,"high":157.53,"amplitude":0.031091,"preClose":157.6,"low":152.63,"week52Low":93.26,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":154.03,"eps":18.23,"divideRate":0.003684,"volume":11300561,"delay":0,"ttmEps":18.23,"open":157.08,"prevYearClose":121.93,"prevWeekClose":156.2,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":161.93,"twentyDayClose":159.53,"sixtyDayClose":140.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664381446","title":"從護膚到大健康，植物醫生想成為一家生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381446","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381446?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 12:39","pubTimestamp":1788496793,"startTime":"0","endTime":"0","summary":"从高山植物护肤，到中国原创成分，再到大健康产品，它正在尝试把高山植物科研从服务于单一护肤品的研发能力，变成一套能够跨品类持续产生价值的科研底座。这个问题的答案，将决定植物医生最终是增加了一条大健康产品线，还是能够真正完成从护肤品牌向生物科技公司的能力跃迁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788496062591431273","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IBBJ","BK4581","IEIH","MEDX","159837","XBI","BK4585","LNGR","SYNB","AGNG","GDOC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664590802","title":"生物醫藥公司扎堆「趕考」港交所，「A+H」上市模式受青睞","url":"https://stock-news.laohu8.com/highlight/detail?id=2664590802","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664590802?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 06:29","pubTimestamp":1788474547,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154879404","title":"醫療保健板塊市場快訊：比特幣漲勢帶動加密市場樂觀情緒，阿斯利康新藥潛力引關注","url":"https://stock-news.laohu8.com/highlight/detail?id=1154879404","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154879404?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 04:58","pubTimestamp":1788469126,"startTime":"0","endTime":"0","summary":"最新一期的医疗保健板块市场快讯已发布，涵盖多家重要企业的动态与分析师观点。比特币自8月以来的上涨走势，为加密货币市场注入了乐观情绪。\"目前，比特币已突破8万美元大关，最新报81,054美元，涨幅达4.7%。\"阿斯利康股价上涨1.5%。在英国市场，一项重大新合同的整合延迟以及劳动力成本正在拖累业绩表现。\"Jefferies维持对Sonic的持有评级，目标价定为每股21.00澳元，该股周三收于18.73澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","LABU","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188599563","title":"醫療健康板塊市場綜述：行業動態與個股追蹤","url":"https://stock-news.laohu8.com/highlight/detail?id=1188599563","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188599563?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 00:22","pubTimestamp":1788452559,"startTime":"0","endTime":"0","summary":"0810 GMT——Berenberg分析师在研究报告中指出，阿斯利康治疗慢性阻塞性肺病的新药若能在所有患者群体中展现出有效性，有望成为该领域的市场领军者。这家英国药企今年早些时候公布的初期试验结果显示，托佐利单抗在既往吸烟者的主要人群及整体人群中均带来了获益，且在不同肺功能阶段皆展现疗效。Berenberg表示：“我们认为减少30%的急性加重将是一个极为积极的结果，且超出预期。”该公司股价上涨1.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","BK4585","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877326","title":"美國衞生與公眾服務部醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.2億美元，用於擴大印第安納州母嬰健康服務，提高初級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877326","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:22","pubTimestamp":1788441723,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0320765489.SGD","SG9999014013.SGD","SG9999014005.SGD","LU1093756325.SGD","IHF","HUM","LU0266013472.USD","RSPH","XLV","SG9999014021.USD","LU1983260115.SGD","LU0238689110.USD","BK4588","LABU","LU0211331839.USD","XBI","LU0348723411.USD","BK4154","LU0417517546.SGD","LU0070302665.USD","BK4581","BK4566","BK4585","LU0170899867.USD","LU0256863811.USD","LU0390134368.USD","LU1093756168.USD","LU0208291251.USD","FXH","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664791008","title":"American Healthcare REIT（AHR）宣佈完成收購八個高端養老社區 涉資近7億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664791008","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664791008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:17","pubTimestamp":1788434240,"startTime":"0","endTime":"0","summary":"金吾财讯 | American Healthcare REIT 宣布以约6.96亿美元的总价收购了八个A级高端老年住宅社区，一举打入供应受限的美国东北部养老地产核心市场。据悉，AHR在完成交易后，将另外两项非核心社区的购买协议以成本价转让给了另一家机构投资者。而随着本次收购落地，AHR在2026年年内完成的总投资额已突破20亿美元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JJJ.SI","AHR","MDIV","SRT.SI","BK4588","YLDW","BK4581","BPRE","XBI","RNTY","BK6142","SRU.SI","8C8U.SI","CFA.SI","XLV","CLR.SI","RJMG","BK4225","BK4585","LABU","DFRA","PSCF","GLS.SI","IQRA","IVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875833","title":"鄉村振興 | 一粒「蛋白」的農田奇遇：看盤山如何用生物科技解鎖豐收密碼","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875833","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875833?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:27","pubTimestamp":1788427620,"startTime":"0","endTime":"0","summary":"与往年不同，今年当地首次将基于蛋白质合成底层技术的生物质高蛋白营养液应用于稻蟹共生产业，为传统农业注入新质生产力。在盘山县禾壮水稻种植专业合作社的650亩稻田里，植保无人机正按照预设航线，将生物质高蛋白营养液均匀喷洒在稻叶上。合作社负责人刘壮专门划出对比试验田，用数据检验科技实效。她表示，蛋白制剂通过优化稻田水体微生态，增强水生生物免疫力，实现水稻提质、河蟹增效的双赢效果。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-03/doc-iniqpzps1035593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HBImain","BK4588","XBI","159837","GDOC","AGNG","BK4585","IBBJ","IEIH","LNGR","MEDX","SYNB","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195881897","title":"醫療保健板塊綜述：市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1195881897","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195881897?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:23","pubTimestamp":1788423797,"startTime":"0","endTime":"0","summary":"澳大利亚国家老年人护理分类起步价上调2.55%，这一幅度远低于Regis Healthcare及其他住宅式老年护理服务商所面临的成本通胀压力。瑞银分析指出，2026财年医疗行业工资通胀率已达3.8%。\"该机构将Regis的目标股价从每股6.75澳元下调至5.95澳元，但维持中性评级。该股目前下跌27%，报4.31澳元。诺华股价下跌0.75%，罗氏股价上涨0.8%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","BK4588","LABU","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664825808","title":"跨國巨頭，入局鄭州航空港區中原醫學科學城","url":"https://stock-news.laohu8.com/highlight/detail?id=2664825808","media":"河南日报客户端","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664825808?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 11:13","pubTimestamp":1788405213,"startTime":"0","endTime":"0","summary":"原标题：跨国巨头入局！正大生物噬菌体项目落户中原医学科学城9月1日，正大生物控股有限公司（以下简称“正大生物”）CEO马德寿一行到访郑州航空港经济综合实验区中原医学科学城，双方围绕噬菌体产业化基地项目以及中长期产业协同开展座谈交流。据了解，正大生物是正大集团旗下核心生物科技板块，总部设于中国香港，系泰国上市企业卜蜂食品企业有限公司（CPF）控股成员企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033863867521.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033863867521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CPF","XBI","BK4211","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843670","title":"這些女性在休產假期間被解僱。是的，這合法，而且可能比你想象的更常見","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843670","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843670?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 00:57","pubTimestamp":1788368220,"startTime":"0","endTime":"0","summary":"妇女与家庭伙伴关系的高级研究员凯瑟琳·加拉格尔·罗宾斯表示，很难说女性在产假期间被解雇有多普遍，但一些指标表明这是一个持续存在的问题。近期数据显示，女性承担了失业的主要冲击。对于处于离职生育和照顾新生儿这一脆弱地位的女性来说，在此期间失业的可能性感觉像一个永远笼罩的威胁。美国确实存在法律保护工人免受因休产假或与怀孕或照顾新生儿相关的其他便利安排而受到歧视。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-03/doc-iniqnieq7440478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","LABU","BK4194","DEI","BK4585","XBI","BK4581","XLV","BK4223"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190612977","title":"醫療保健板塊市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1190612977","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190612977?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 00:26","pubTimestamp":1788366410,"startTime":"0","endTime":"0","summary":"该分析师在研究报告中写道，公司对盈利能力的展望比市场预期更为乐观。Equita SIM维持对该股的买入评级。截至发稿，股价报157.95欧元，下跌1%。2208 ET - CIMB证券分析师Chun Sung Oong在报告中表示，德里高等法院任命法务审计师追查与前Fortis发起人Malvinder Singh和Shivinder Singh相关的涉嫌资产转移事件，对IHH医疗的直接影响可能微乎其微。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4588","BK4581","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664989046","title":"北京：聚焦集成電路、生物醫藥、航空航天、高端裝備等優勢產業，鞏固對外貿易傳統市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2664989046","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664989046?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:30","pubTimestamp":1788341448,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4564","BK4588","UFO","BK4581","PPA","XBI","XAR","BK4585","DFEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897210","title":"派格生物醫藥-B(02565.HK)與SN BioScience訂立材料轉移協議 推進包括APGP6在內的三款下一代代謝疾病創新多肽候選藥物長效化開發","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897210","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897210?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:03","pubTimestamp":1788339819,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4191","BK4581","LU0029874061.USD","BK4588","BK4585","LU0128526141.USD","SN","XBI","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182230701","title":"醫療保健板塊動態：市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1182230701","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182230701?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 04:56","pubTimestamp":1788296217,"startTime":"0","endTime":"0","summary":"针对自身免疫性疾病及神经系统疾病的实验性疗法临床试验，诺华公司决定按下暂停键。此前，该试验中有三名患者不幸离世，这令投资者们心生警惕。\"与此同时，另一项关于多发性硬化症药物的独立研究传来了积极结果，受此提振，诺华股价攀升5.9%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","XBI","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664857540","title":"貫徹實施民營經濟促進法典型案例（第二批）","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857540","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664857540?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:12","pubTimestamp":1788271920,"startTime":"0","endTime":"0","summary":"在《中华人民共和国民营经济促进法》实施一周年之际，国家发展改革委、最高人民法院联合发布贯彻实施民营经济促进法典型案例（第二批），聚焦民企纾困、权益保护、公平营商、涉外解纷四大核心领域，以鲜活裁判打通法条落地“最后一公里”。该案成功办理充分体现了《中华人民共和国民营经济促进法》第二十七条、第三十三条、第七十四条规定精神，检察机关通过加大对创新成果的知识产权保护力度，为企业自主创新提供有力保障。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-01/doc-iniqixxq1485773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664276851","title":"【「十五五」開局看趙縣——生物醫藥篇】創新驅動增動能 科技賦能產業升級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664276851","media":"赵州发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664276851?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 20:38","pubTimestamp":1788266280,"startTime":"0","endTime":"0","summary":"“十五五”开局之年，赵县锚定百亿级生物医药产业集群建设目标，引导生物医药企业把科技创新摆在发展突出位置，持续建强科研载体、深化产学研协同，积极探索新型研发合作模式，以技术攻关激活产业内生新动能。立足“十五五”开局，赵县持续引导生物医药企业强化科研攻关，厚植创新沃土，不断激活产业内生动力，全力向着百亿级生物医药产业集群建设目标稳步迈进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-01/doc-iniqitru8318929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","399441","BK4581","XBI","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985878","title":"北京成立生物醫藥等三個共保體 支持科技創新","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985878","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985878?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 18:33","pubTimestamp":1788258782,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664026884","title":"百濟神州：PD-1抗癌藥降價加入美國公共醫療保險計劃 今後上市創新藥均將執行最惠國定價","url":"https://stock-news.laohu8.com/highlight/detail?id=2664026884","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664026884?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 09:36","pubTimestamp":1788226577,"startTime":"0","endTime":"0","summary":"美国当地时间8月31日，美国总统特朗普宣布与9家制药企业达成全新协议，为美国民众下调处方药价格，药价对标其他发达国家的最低采购价，即“最惠国（MFN）价格”，其中包括国内创新药龙头百济神州。9月1日，百济神州对《每日经济新闻》记者表示，根据协议，百济神州将通过Medicaid项目，以约定的价格向符合条件的患者提供替雷利珠单抗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609013861069086.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609013861069086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1719994722.HKD","LU1169590202.USD","BK1500","LU2328871848.SGD","LNGR","LU1770034418.SGD","LU0228659784.USD","159992","CANC","LU1303224171.USD","BK4023","BK4139","IPOS","LU1251922891.USD","06978","PD","XBI","BK1588","MEDX","LU0307460666.USD","BK4585","KURE","688235","BK4581","BK4526","LU0588546209.SGD","LU1169589451.USD","XLV","BK1583","06160","LU0828237510.HKD","BK1574","ONC","BK1161","LABU","LU1969619763.USD","IBBQ","BK0239","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664074520","title":"生物醫藥邁向「源頭創新」","url":"https://stock-news.laohu8.com/highlight/detail?id=2664074520","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664074520?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:45","pubTimestamp":1788194700,"startTime":"0","endTime":"0","summary":"截至8月31日，A股、港股生物医药上市公司2026年半年报已全部披露完毕。从披露的经营数据来看，今年上半年，生物医药行业业绩分化进一步加剧，传统药企承压转型，创新药企盈利拐点显现。其中，头部药企研发投入稳步攀升、创新动能不断积聚，叠加国际化提速、AI制药应用加快，展现出中国生物医药正迎来从“跟随创新”向“源头创新”的关键转折。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609013860522190.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609013860522190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["399441","XBI","BK4588","BK4585","BK4581","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663407606","title":"北京：聚焦集成電路、生物醫藥、航空航天、高端裝備等優勢產業，鞏固對外貿易傳統市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2663407606","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663407606?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 17:26","pubTimestamp":1788168364,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","XAR","BK4585","UFO","BK4581","XBI","PPA","BK4564","DFEN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}